Respiratory distress

Pediatric Annals

Volumn 34, Issue 11, 2005, Pages 885-891

  Fallot, André ^a,b,c  

^a San Antonio Military Pediatric Center ^*  (United States)

^b US Army Medical Corps   (United States)

^c San Antonio Military Pediatric Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; IPRATROPIUM BROMIDE; LEVALBUTEROL; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; SALBUTAMOL; TERBUTALINE;

AIRWAY; ALERTNESS; ALGORITHM; ASTHMA; ASTHMATIC STATE; AUSCULTATION; BREATHING; BREATHING APPARATUS; BREATHING RATE; BRONCHIOLITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CROUP; CYANOSIS; EDEMA; EMERGENCY; GAS EXCHANGE; HUMAN; LARYNGOTRACHEOBRONCHITIS; LONG TERM CARE; METERED DOSE INHALER; PARADOXICAL PULSE; PEDIATRICS; PULSE OXIMETRY; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; REVIEW; STRIDOR; TACHYPNEA; VIRAL BRONCHIOLITIS; WHEEZING;

EID: 27844513301     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20051101-12     Document Type: Review

References (34)

1. American Heart Association, American Academy of Pediatrics, eds. PALS Provider Manual. Dallas, TX: American Heart Association; 2002.
2. Dolovich MB, Ahrens RC, Hess DR, et al.; American College of Chest Physicians, American College of Asthma, Allergy, and Immunizations. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335-371.
3. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulisers. Arch Dis Child. 1992;67(5):586-591.
4. Lowenthal D, Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol. 1992;14(3): 192-196.
5. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics. 2001;108(2):389-394.
6. Helfaer M. Textbook of Pediatric Intensive Care. 3rd ed. Baltimore, MD: Williams and Wilkins; 1996.
7. Gorelick MH, Stevens MW, Schultz TR, Scribano PV. Performance of a novel clinical score, the Pediatric Asthma Seventy Score (PASS), in the evaluation of acute asthma. Acad Emerg Med. 2004;11(1):10-18.
8. Carl JC, et al. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma. J Pediatr. 2003;143(6):731-736.
9. Kornberg AE, Zuckerman S, Welliver JR, Mezzadri F, Aquino N. Effect of injected long-acting epinephrine in addition to aerosolized albuterol in the treatment of acute asthma in children. Pediatr Emerg Care. 1991;7(1):1-3.
10. Victoria MS, Battista CJ, Nangia BS. Comparison between epinephrine and terbutaline injections in the acute management of asthma. J Asthma. 1989;26(5):287-290.
11. Payne DN, Balfour-Lynn IM, Biggart EA, Bush A, Rosenthal M. Subcutaneous terbutaline in children with chronic severe asthma. Pediatr Pulmonol. 2002;33(5):356-361.
12. Simons FE, Gillies JD. Dose response of subcutaneous terbutaline and epinephrine in children with acute asthma. Am J Dis Child. 1981;135(3):214-217.
13. Moler FW, Hurwitz ME, Custer JR. Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol. 1988;81(6):1101-1109.
14. Montgomery VL, Eid NS. Low-dose beta-agonist continuous nebulization therapy for status asthmaticus in children. J Asthma. 1994;31(3):201-207.
15. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993;21(10):1479-1486.
16. Guidelines for the Diagnosis and Management of Asthma - Update on Selected Topics, National Heart, Lung, and Blood Institute. National Asthma and Education and Prevention Program. 2002. Available at: http://www. nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed October 18, 2005.
17. Becker JM, Arora A, Scarfone RJ, et al. Oral versus intravenous corticosteroids in children hospitalized with asthma. J Allergy Clin Immunol. 1999;103(4):586-590.
18. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;(1):CD002178.
19. Barnes PJ. Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis. 1990;141(2 Pt 2):S70-S76.
20. Rachelefsky G. Treating exacerbations of asthma in children: the role of systemic corticosteroids. Pediatrics. 2003;112(2):382-397.
21. Global Strategy for Asthma Management and Prevention. National Institutes of Health. National Heart, Lung and Blood Institute. 2002. NIH Publication No 02-3659.
22. Plotnick LH, Ducharme FM. Acute asthma in children and adolescents: should inhaled anticholinergics be added to beta(2)-agonists? Am J Respir Med. 2003;2(2):109-115.
23. Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med. 1998;339(15):1030-1035.
24. Zorc JJ, Pusic MV, Ogborn CJ, Lebet R, Duggan AK. Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics. 1999; 103(4 Pt 1):748-752.
25. Craven D, Kercsmar CM, Myers TR, O'riordan MA, Golonka G, Moore S. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. J Pediatr. 2001;138(1):51-58.
26. Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2004;(3):CD004878.
27. King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004;158(2):127-137.
28. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2004;(1): CD003123.
29. Mallory MD, Shay DK, Garrett J, Bordley WC. Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics. 2003;111(1):e45-e51.
30. Denny FW, Murphy TF, Clyde WA Jr, Collier AM, Henderson FW. Croup: an 11-year study in a pediatric practice. Pediatrics. 1983;71(6):871-876.
31. Russell K, Wiebe N, Saenz A, et al. Glucocorticoids for croup. Cochrane Database Syst Rev. 2004;(1):CD001955.
32. Kristjansson S, Berg-Kelly K, Winso E. Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup. Clinical symptom score and oxygen saturation measurements for evaluation of treatment effects. Acta Paediatr. 1994;83(11):1156-1160.
33. Ledwith CA, Shea LM, Mauro RD. Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup. Ann Emerg Med. 1995;25(3):331-337.
34. Rizos JD, DiGravio BE, Sehl MJ, Tallon JM. The disposition of children with croup treated with racemic epinephrine and dexamethasone in the emergency department. J Emerg Med. 1998;16(4):535-539.